YTHDC2 and lymphoid neoplasm: The expression level of YTHDC2 was significantly upregulated in CHOL, lymphoid neoplasm diffuse large B‐cell lymphoma (DLBC), kidney renal clear cell carcinoma (KIRC), acute myeloid leukaemia (LAML), LGG, pancreatic adenocarcinoma (PAAD) and thymoma (THYM).